*Some individuals may need a more aggressive dosing regimen, therefore the RX may not last the full 15 weeks.
This monthly subscription program includes semaglutide and weekly follow-ups as needed via telemedicine or in person; Our most popular and successful program! Pricing consists of all medication and supplies as well as unlimited refills while you are subscribed to the program..
Control cravings and reduce your appetite to achieve significant weight loss with the newest prescription peptide for weight management.
Semaglutide and B12 Vial sold individually.
Tirzepatide and B12 Vial sold individually
The added b12 will help prevent you from feeling fatigued or having low energy levels during a low-calorie diet, keeping you motivated to burn more fat.
subscription-based plan includes oral appetite suppressant with once monthly follow-up.
Do you struggle to lose weight? Excess weight is largely a result of eating habits but with busy lifestyles, everyday stress, and our modern food supply; not to mention hormones and genetics, it seems we are set up to fail. Semaglutide helps control appetite and cravings, setting you up for success.
Semaglutide is a glucagon-like peptide (GLP-1) analog. GLP-1 is a hormone produced in the small intestine that stimulates insulin secretion and inhibits glucagon secretion, thereby lowering blood sugar. Studies show that Semaglutide reduces appetite, improves control of eating, and reduces food cravings in addition to improving glycemic control.
Anecdotally, this peptide has been described by doctors as twice as effective as any prescription weight loss products on the market today, likening it to the equivalent of having gastric bypass surgery.
Semaglutide trial results showed overweight or obese adults receiving weekly Semaglutide had a mean weight loss of 14.9% at 68 weeks. In this same study, nearly 70% of participants were able to achieve a 10% weight loss threshold by taking Semaglutide. And 32% of participants lost at least 20% of their initial weight.
Below are some recent research articles:
Singh, G., Krauthamer, M., & Bjalme-Evans, M. (2022). Wegovy (Semaglutide): a new weight loss drug for chronic weight management. Journal of Investigative Medicine, 70(1), 5-13.
Zhong, P., Zeng, H., Huang, M., Fu, W., & Chen, Z. (2022). Efficacy and safety of once-weekly Semaglutide in adults with overweight or obesity: a meta-analysis. Endocrine, 1-7.
Iqbal, J., Wu, H. X., Hu, N., Zhou, Y. H., Li, L., Xiao, F., … & Zhou, H. D. (2022). Effect of glucagon‐like peptide‐1 receptor agonists on body weight in adults with obesity without diabetes mellitus—a systematic review and meta‐analysis of randomized control trials. Obesity Reviews, e13435.
Weekly as a subcutaneous injection, commonly dosed once a week. Dosing may be increased as needed. You can administered on you on or come in weekly or as needed for support.
Most reported side effects are nausea, diarrhea, stomach pain, and constipation.
ADVANCED MEDICAL WEIGHT LOSS
We can help you reach your weight loss goals with a custom plan designed for you.
Schedule your consultation and take the next step toward your overall health.
Control cravings and reduce your appetite to achieve significant weight loss with the newest FDA-approved prescription peptide for weight management.
Our 10-week weight loss package includes consultation and FDA approved Semaglutide.
We also include or easy to follow diet and exercise plan for free. *10-week supply of Semaglutide is based on following the FDA dosing regimen.
Sign Up Now For Updates& Discounts
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. This service is intended for healthy adults.
TRAVEL FEE WILL APPLY FOR CONCIERGE IV MOBILE VISITS
Copyright 2022 © Wellness IV Bar
New Clients can schedule an appointment below. Please fill out this form or call/text us at 813.290.1994